期刊文献+

阿托伐他汀对脑梗死患者C反应蛋白及血脂的影响

Effects of Atorvastatin on C-reactive Protein and Blood Lipid in Cerebral Infarct Patient
在线阅读 下载PDF
导出
摘要 目的探讨阿托伐他汀对脑梗死患者C反应蛋白及血脂的影响。方法对45例患者给予阿托伐他汀10mg,口服,1次/d,疗程4周。观察治疗前后血清C反应蛋白及血脂浓度的变化。结果患者在用药4周后,其血清C反应蛋白、胆固醇、甘油三酯、低密度脂蛋白显著降低,高浓度脂蛋白明显上升。结论阿托伐他汀是一安全、高效的降脂药物,可在短时间内降低血脂水平,减少脑血管病的危险因素。 Objective To explore the effect of atorvastatin of C - reactive protein and blood lipid in patients with cerebral infarction. Methods Total 45cases of cerebral infraction were given atorvatatin 10mg once a day for four weeks. The levels of CRP and blood lipid were measured before and after four weeks. Results The levels of CRP,cholesterol,triglyeerides and LDL - C decreased sig- nificantly and the levels of HDL - C increased significantly, after atorvatatin therapy. Conclusion Atorvastatin may play an important role in reducing the risk of eerebrovascular disease and can reduce blood lipid to normal in a short period.
作者 李峰
出处 《医药论坛杂志》 2008年第20期3-4,共2页 Journal of Medical Forum
关键词 阿托伐他汀 脑梗死 C反应蛋白 血脂 Atorvastatin Cerebral infarction C - reactive protein Blood lipid
  • 相关文献

参考文献9

二级参考文献93

共引文献33274

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部